2-156325324-CTG-C
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_006186.4(NR4A2):c.*418_*419delCA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.44 in 216,878 control chromosomes in the GnomAD database, including 18,725 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.44 ( 15514 hom., cov: 0)
Exomes 𝑓: 0.44 ( 3211 hom. )
Consequence
NR4A2
NM_006186.4 3_prime_UTR
NM_006186.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.22
Genes affected
NR4A2 (HGNC:7981): (nuclear receptor subfamily 4 group A member 2) This gene encodes a member of the steroid-thyroid hormone-retinoid receptor superfamily. The encoded protein may act as a transcription factor. Mutations in this gene have been associated with disorders related to dopaminergic dysfunction, including Parkinson disease, schizophernia, and manic depression. Misregulation of this gene may be associated with rheumatoid arthritis. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 2-156325324-CTG-C is Benign according to our data. Variant chr2-156325324-CTG-C is described in ClinVar as [Benign]. Clinvar id is 331653.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.54 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NR4A2 | NM_006186.4 | c.*418_*419delCA | 3_prime_UTR_variant | 8/8 | ENST00000339562.9 | NP_006177.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NR4A2 | ENST00000339562 | c.*418_*419delCA | 3_prime_UTR_variant | 8/8 | 1 | NM_006186.4 | ENSP00000344479.4 |
Frequencies
GnomAD3 genomes AF: 0.439 AC: 65975AN: 150230Hom.: 15510 Cov.: 0
GnomAD3 genomes
AF:
AC:
65975
AN:
150230
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.442 AC: 29438AN: 66544Hom.: 3211 AF XY: 0.436 AC XY: 15371AN XY: 35244
GnomAD4 exome
AF:
AC:
29438
AN:
66544
Hom.:
AF XY:
AC XY:
15371
AN XY:
35244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.439 AC: 65977AN: 150334Hom.: 15514 Cov.: 0 AF XY: 0.435 AC XY: 31884AN XY: 73352
GnomAD4 genome
AF:
AC:
65977
AN:
150334
Hom.:
Cov.:
0
AF XY:
AC XY:
31884
AN XY:
73352
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Parkinson Disease, Dominant/Recessive Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at